Assessment of the Innovation Model of the Research Operations of a Global Pharmaceutical Player
Project Context and Scope
As part of defining the long-term strategy for a global pharmaceutical company, the head of research engaged Catenion to help assess the strengths and weaknesses of the company’s innovation model.
Approach: 2 Partners, 1 Consultant, for 3 Months
Catenion supported an internal client team that was looking at the the quality and quantity of innovation coming out of research. Catenion provided:
- An assessment of barriers to innovation built into the way the organisation worked
- External benchmarking and analysis of the innovation models of
- Peer pharmaceutical companies
- Successful academic institutions
- Other industries
The Catenion team interviewed 80 employees, representing a cross–section of the client’s research organisation at seven sites in Europe and North America.
The analysis was complemented by a quick scan of the innovativeness of the current and past research pipeline and showed clear issues at the levels of structure, processes, governance and incentives.
Key Benefits to the Client
- Catenion’s findings were initially met with skepticism from the team, which was eventually won over and became a major driver for change in the organisation.
- The barriers to innovation became clear, as well as the steps to overcoming them.
- As a result, the client embarked on a major redesign of the research organisation.